We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$1.71M
Cap. Flow
-$65.7M
Cap. Flow %
-3.73%
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14

Top Buys

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$15M
2
EB
Eventbrite
EB
+$9.72M
3
ESTA icon
Establishment Labs
ESTA
+$9.35M
4
PRO
PROS Holdings
PRO
+$7.11M
5
PCRX icon
Pacira BioSciences
PCRX
+$6.75M

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$13.7M
2
MED icon
Medifast
MED
+$11.8M
3
PINC
Premier
PINC
+$11M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$8M
5
MEDP icon
Medpace
MEDP
+$7.15M

Sector Composition

Rank Sector Weight
1 Healthcare 28.23%
2 Technology 24.76%
3 Industrials 19.11%
4 Consumer Discretionary 9.18%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ERII icon
101
Energy Recovery
ERII
$443M
$4.19M 0.24%
149,923
-71,856
-32% -$1.79M
STRL icon
102
Sterling Infrastructure
STRL
$16.7B
$4.08M 0.23%
73,160
-39,719
-35% -$1.76M
TTEK icon
103
Tetra Tech
TTEK
$9.07B
$4.07M 0.23%
124,420
-10
-0% -$294
THR
104
DELISTED
Thermon Group Holdings
THR
$4.01M 0.23%
150,889
-18,276
-11% -$424K
LUNA
105
DELISTED
Luna Innovations Incorporated
LUNA
$3.97M 0.23%
435,392
-47,978
-10% -$380K
LOB icon
106
Live Oak Bancshares
LOB
$1.97B
$3.95M 0.22%
150,193
-10,033
-6% -$236K
ALG icon
107
Alamo Group
ALG
$2.05B
$3.93M 0.22%
21,385
-2,484
-10% -$443K
LNTH icon
108
Lantheus
LNTH
$6.59B
$3.89M 0.22%
46,394
+1,407
+3% +$126K
KRTX
109
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.89M 0.22%
17,916
-283
-2% -$60.6K
OMCL icon
110
Omnicell
OMCL
$1.68B
$3.87M 0.22%
52,538
+8,263
+19% +$557K
SLP icon
111
Simulations Plus
SLP
$371M
$3.76M 0.21%
86,810
-10,081
-10% -$441K
LASR icon
112
nLIGHT
LASR
$3.17B
$3.69M 0.21%
239,578
-25,114
-9% -$307K
IRD
113
Opus Genetics
IRD
$302M
$3.69M 0.21%
849,286
+40,169
+5% +$191K
HRMY icon
114
Harmony Biosciences
HRMY
$2.24B
$3.61M 0.2%
102,550
-17,942
-15% -$619K
DEN
115
DELISTED
Denbury Inc.
DEN
$3.6M 0.2%
41,687
-711
-2% -$64.4K
USPH icon
116
US Physical Therapy
USPH
$1.22B
$3.58M 0.2%
29,473
-3,795
-11% -$409K
MATV icon
117
Mativ Holdings
MATV
$711M
$3.55M 0.2%
235,084
-15,177
-6% -$269K
CDMO
118
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$3.53M 0.2%
+252,723
New +$4.31M
XPEL icon
119
XPEL
XPEL
$1.38B
$3.53M 0.2%
41,874
-5,393
-11% -$399K
HAYN
120
DELISTED
Haynes International, Inc.
HAYN
$3.49M 0.2%
68,720
+10,157
+17% +$483K
ENSG icon
121
The Ensign Group
ENSG
$10.7B
$3.49M 0.2%
36,564
-28
-0.1% -$2.64K
LQDT icon
122
Liquidity Services
LQDT
$1.32B
$3.45M 0.2%
209,022
+9,913
+5% +$145K
VICR icon
123
Vicor
VICR
$10.2B
$3.43M 0.19%
63,600
-1,653
-3% -$81.6K
VPG icon
124
Vishay Precision Group
VPG
$914M
$3.41M 0.19%
91,892
-11,186
-11% -$416K
CBZ icon
125
CBIZ
CBZ
$2.96B
$3.32M 0.19%
62,256
-7,591
-11% -$391K
3 4
5
6 7

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Rice Hall James & Associates held 276 positions worth $1.76B, up 0.1% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.7M in Q2 2023, closing 14 positions and reducing 180 holdings. Its most notable exit was Semtech, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in BioCryst Pharmaceuticals worth $13.2M.

  • Rice Hall James & Associates's largest Q2 2023 buy was BioCryst Pharmaceuticals: 1,872,964 shares worth $13.2M.
  • Rice Hall James & Associates added most to Eventbrite in Q2 2023, an estimated $9.72M increase.
  • Rice Hall James & Associates's biggest Q2 2023 reduction was Premier, cutting an estimated $11M.
  • Rice Hall James & Associates fully exited Semtech in Q2 2023, selling an estimated $13.7M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.76B portfolio in Q2 2023.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q2 2023.
  • Rice Hall James & Associates's portfolio value rose 0.1% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.